Showing posts with label Cisplatin. Show all posts
Showing posts with label Cisplatin. Show all posts
Friday, January 22, 2010
Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer
"METHODS:: Patients with stage III/IV EOC received cyclophosphamide 750 mg/m(2), followed by a 24-hour infusion of paclitaxel 250 mg/m(2) and cisplatin 75 mg/m(2) on Day 2. Filgrastim began on Day 3 at 10 mug/kg daily for 9 days. Patients received 6 cycles of all drugs." CONCLUSIONS:: The studied regimen yielded a high response rate and encouraging overall survival."
add your opinions
10 year followup
,
Cisplatin
,
Cyclophosphamide
,
Filgrastim
,
ovarian cancer
,
Paclitaxel
Subscribe to:
Posts
(
Atom
)